Amgen News

This is a continuation of my previous article on biotechnology stocks to watch ahead of ASCO 2012.

Amgen, the world's largest biotechnology company, continues to lead the payrolls of the most well-compensated executives in the region's public companies, with its top three bosses earning a combined $31.7 million last year.

This is a continuation of my previous article on biotechnology stocks to watch ahead of ASCO 2012.

THOUSAND OAKS, Calif., May 23, 2012 /PRNewswire/ -- Amgen today announced voting results from the Company's Annual Meeting of Stockholders, held at the Four Seasons Hotel, Westlake Village, Calif.

Rose Delfino signs a petition while protesting outside the Amgen Inc. stockholders meeting Wednesday at the Four Seasons Hotel in Westlake Village.

Biotech drugmaker Amgen Inc. has introduced new CEO Bob Bradway to shareholders at the company's annual meeting, with retiring CEO Kevin Sharer stepping down after a decade.

SANTA CRUZ, Calif. -- -- Early and late stage innovators, investors and pharma partners come together at C21 BioVentures .

Q: I was driving west on Panorama Drive and noticed the resurfacing of the street and a very long stretch of chain link fence, which seemed to be preparation for the Amgen race.

Dachshund mix Phoenix and pit-bull mix Natalia have been undergoing treatment at the Pet Emergency Clinics and Specialty Hospital in Thousand Oaks with help from the Grossman Burn Center at West Hills Hospital.

Stage 6 of the Amgen Tour of California went to France's Sylvain Georges of AG2R-La Mondiale.

Tom Berube, who rides his bike from Simi Valley to Amgen, where he works, stops to speak with Kathy Lowry, city of Thousand Oaks bike coordinator, who gives him food and a bag of free bike goods Friday as part of the National Bike to Work Day in Thousand Oaks.

Developments, news and strategies for drug development specific to phase I through Phase III global clinical trial management, execution, project management and outsourcing.

In the news release, Amgen's BiTE Antibody Blinatumomab Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, issued by Amgen over PR Newswire, we are advised by the company that the third paragraph now includes additional safety information.

Incoming Amgen chief Robert Bradway takes the baton from longtime CEO Kevin Sharer as the world's largest biotech company makes critical decisions about how it will compete with Big Pharma and biosimilars.

The Amgen Tour of California leaves Bakersfield today and moves on to the desertA and the city of Palmdale for stage 6 of the 8-stage bicycle race on Friday.

MAY 16: Overall race leader Peter Sagan of Slovakia riding for Liquigas-Cannondale signs autographs for fans prior to the start of stage four of the Amgen Tour of California from Sonora to Clovis on May 16, 2012 in Sonora, California.

Very few sectors have been able to avoid the sell-off in May. The strongest of the group has been the biotech stocks, which measured by the Dow Jones Biotechnology Index, is at an all-time high.

THOUSAND OAKS, Calif., May 16, 2012 /PRNewswire/ -- Amgen announced today results from an exploratory biomarker analysis evaluating MET expression as a predictor of clinical response to rilotumumab .

Amgen's BiTE? Antibody Blinatumomab Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia Greater than 70 Percent of Patients in the Study Achieved Complete Response Median Survival 9.0 Months, with a Median Follow-up of 10.7 Months Amgen's BiTE Antibody Blinatumomab Achieved High Rate of ... (more)

MAY 15: Peter Sagan of Slovokia riding for Liquigas-Cannondale signs autographs for fans before stage three of the Amgen Tour of California from San Jose to Livermore on May 15, 2012 in San Jose, California.